The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?
about
Cytokeratin phenotyping does not help in distinguishing oesophageal adenocarcinoma from cancer of the gastric cardia.Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.The effect of oral administration of ursodeoxycholic acid and high-dose proton pump inhibitors on the histology of Barrett's esophagus.
P2860
The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of short-segment Barrett esophagus from gastric intestinal metaplasia: Is it reliable?
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The utility of cytokeratins 7 ...... al metaplasia: Is it reliable?
@ast
The utility of cytokeratins 7 ...... al metaplasia: Is it reliable?
@en
The utility of cytokeratins 7 ...... al metaplasia: Is it reliable?
@nl
type
label
The utility of cytokeratins 7 ...... al metaplasia: Is it reliable?
@ast
The utility of cytokeratins 7 ...... al metaplasia: Is it reliable?
@en
The utility of cytokeratins 7 ...... al metaplasia: Is it reliable?
@nl
prefLabel
The utility of cytokeratins 7 ...... al metaplasia: Is it reliable?
@ast
The utility of cytokeratins 7 ...... al metaplasia: Is it reliable?
@en
The utility of cytokeratins 7 ...... al metaplasia: Is it reliable?
@nl
P2093
P2860
P356
P1476
The utility of cytokeratins 7 ...... al metaplasia: Is it reliable?
@en
P2093
Erol Avsar
Nadi Bakirci
Nurdan Tozun
Ozlem Kurtkaya-Yapicier
Rasim Gencosmanoglu
P2860
P2888
P356
10.1186/1472-6890-3-5
P50
P577
2003-12-02T00:00:00Z